The effects of long-term clozapine add-on therapy on the rehospitalization rate and the mood polarity patterns in bipolar disorders

Journal of Clinical Psychiatry

Volumn 67, Issue 3, 2006, Pages 461-467

  Chang, Jae Seung ^a   Ha, Kyoo Seob ^b,c   Lee, Kyu Young ^a,c   Kim, Yong Sik ^a,c   Ahn, Yong Min ^a,c  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; LITHIUM; LITHIUM CARBONATE; MOOD STABILIZER; SERTRALINE; VALPROIC ACID;

ADD ON THERAPY; ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG STABILITY; FEMALE; HOSPITAL READMISSION; HUMAN; HYPERSALIVATION; HYPOMANIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MANIA; MOOD CHANGE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEDATION; SIDE EFFECT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 33645758058     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n0318     Document Type: Article

References (55)

1. Dickerson FB, Sommerville J, Origoni AE, et al. Outpatients with schizophrenia and bipolar I disorder: do they differ in their cognitive and social functioning? Psychiatry Res 2001;102:21-27
2. Ertugrul A, Meltzer HY. Antipsychotic drugs in bipolar disorder. Int J Neuropsychopharmacol 2003;6:277-284
3. Goldberg JF, Harrow M. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up. J Affect Disord 2004;81:123-131
4. Joyce PR. Illness behaviour and rehospitalization in bipolar affective disorder. Psychol Med 1985;15:521-525
5. Post RM, Rubinow DR, Ballenger JC. Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry 1986;149: 191-201
6. Prien RF, Gelenberg AJ. Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry 1989;146:840-848
7. Goldberg JF, Harrow M, Leon AC. Lithium treatment of bipolar affective disorders under naturalistic follow-up conditions. Psychopharmacol Bull 1996;32:47-54
8. Kimmel SE, Calabrese JR, Woyshville MJ, et al. Clozapine in treatment-refractory mood disorders. J Clin Psychiatry 1994;55(9, suppl B):91-93
9. Vacheron-Trystram MN, Braitman A, Cheref S, et al. Antipsychotics in bipolar disorders [in French]. Encephale 2004;30:417-424
10. Post RM, Ketter TA, Denicoff K, et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology (Berl) 1996;128:115-129
11. Goldberg JF, Harrow M, Grossman LS. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 1995;152:379-384
12. Sachs GS. Treatment-resistant bipolar depression. Psychiatr Clin North Am 1996;19:215-236
13. Shin YC, Bahk W-M, Kim C-H, et al. Feasibility of Korean medication algorithm for bipolar disorder, 2: choice of medications. Korean J Psychopharmacol 2005;16:285-291
14. Kim C-H, Min KJ, Shin YC, et al. Feasibility of Korean medication algorithm for bipolar disorder, 1: global assessment. Korean J Psychopharmacol 2005;16:225-233
15. Sachs GS, Printz DJ, Kahn DA, et al. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med 2000;Spec No:1-104
16. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
17. Wahlbeck K, Cheine M, Essali A, et al. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 1999;156:990-999
18. Conley RR, Tamminga CA, Kelly DL, et al. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry 1999;46:73-77
19. Wagstaff A, Perry C. Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder. CNS Drugs 2003;17:273-280
20. 2 dopamine antagonists. Neuropsychopharmacology 1996;14(3 suppl):35S-39S
21. Frankenburg FR, Zanarini MC. Uses of clozapine in nonschizophrenic patients. Harv Rev Psychiatry 1994;2:142-150
22. Zarate CA Jr, Tohen M, Banov MD, et al. Is clozapine a mood stabilizer? J Clin Psychiatry 1995;56:108-112
23. Green AI, Tohen M, Patel JK, et al. Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 2000;157:982-986
24. Calabrese JR, Meltzer HY, Markovitz PJ. Clozapine prophylaxis in rapid cycling bipolar disorder [letter]. J Clin Psychopharmacol 1991;11:396-397
25. Suppes T, McElroy SL, Gilbert J, et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992;32:270-280
26. Banov MD, Zarate CA Jr, Tohen M, et al. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994;55:295-300
27. Brambilla P, Barale F, Soares JC. Atypical antipsychotics and mood stabilization in bipolar disorder. Psychopharmacology (Berl) 2003;166:315-332
28. Barbini B, Scherillo P, Benedetti F, et al. Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol 1997;12:109-112
29. Masi G, Mucci M, Millepiedi S. Clozapine in adolescent inpatients with acute mania. J Child Adolesc Psychopharmacol 2002;12:93-99
30. Calabrese JR, Kimmel SE, Woyshville MJ, et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996;153:759-764
31. Fehr BS, Ozcan ME, Suppes T. Low doses of clozapine may stabilize treatment-resistant bipolar patients. Eur Arch Psychiatry Clin Neurosci 2005;255:10-14
32. Narendran R, Young CM, Valenti AM, et al. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study. J Clin Psychiatry 2001;62:509-516
33. Bowden CL. Treatment options for bipolar depression. J Clin Psychiatry 2005;66(suppl 1):3-6
34. Frye MA, Ketter TA, Altshuler LL, et al. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Disord 1998;48:91-104
35. Kane JM, Honigfeld G, Singer J, et al. Clozapine in treatment-resistant schizophrenics. Psychopharmacol Bull 1988;24:62-67
36. Sachs GS, Grossman F, Ghaemi SN, et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159:1146-1154
37. Hillert A, Maier W, Wetzel H, et al. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome: a functional approach. Pharmacopsychiatry 1992;25:213-217
38. Baldessarini RJ, Hennen J, Wilson M, et al. Olanzapine versus placebo in acute mania: treatment responses in subgroups. J Clin Psychopharmacol 2003;23:370-376
39. McIntyre RS, Konarski JZ. Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry 2005;66(suppl 3):28-36
40. Kruger S, Trevor Young L, Braunig P. Pharmacotherapy of bipolar mixed states. Bipolar Disord 2005;7:205-215
41. Dunner DL. Atypical antipsychotics: efficacy across bipolar disorder subpopulations. J Clin Psychiatry 2005;66(suppl 3):20-27
42. McElroy SL, Keck PE Jr, Pope HG Jr, et al. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992;149:1633-1644
43. Akiskal HS. The dark side of bipolarity: detecting bipolar depression in its pleomorphic expressions. J Affect Disord 2005;84:107-115
44. Kruger S, Cooke RG, Spegg CC, et al. Relevance of the catatonic syndrome to the mixed manic episode. J Affect Disord 2003;74:279-285
45. Grof P. Selecting effective long-term treatment for bipolar patients: monotherapy and combinations. J Clin Psychiatry 2003;64(suppl 5):53-61
46. Chiles JA, Davidson P, McBride D. Effects of clozapine on use of seclusion and restraint at a state hospital. Hosp Community Psychiatry 1994;45:269-271
47. Smith H, White T. The effect of clozapine on the social behaviour schedule in patients attending a forensic psychiatry day hospital. Med Sci Law 2004;44:213-216
48. Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003;60:82-91
49. Citrome L, Volavka J, Czobor P, et al. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Psychiatr Serv 2001;52:1510-1514
50. Suppes T, Webb A, Paul B, et al. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999;156: 1164-1169
51. Chengappa KN, Ebeling T, Kang JS, et al. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 1999;60:477-484
52. Hammock R, Levine WR, Schroeder SR. Brief report: effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation. J Autism Dev Disord 2001;31:109-113
53. Colom F, Vieta E, Reinares M, et al. Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement. J Clin Psychiatry 2003;64: 1101-1105
54. Colom F, Vieta E, Martinez-Aran A, et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003;60:402-407
55. Sajatovic M, Davies M, Hrouda DR. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr Serv 2004;55:264-269